Pharmaceutical Industry and Public Policy in Post-reform India Critical Political Economy of South Asia Series
Auteur : Joseph Reji K.
1. Introduction 2. An Overview of Indian Pharmaceutical Industry and Health 3. Patterns of Trade in the Indian Pharmaceutical Industry 4. Pharmaceutical R&D in India 5. IPRs and Access to Medicines 6. The Drug Price Control System in India and Access to Medicines 7. Summary and Conclusion
Reji K. Joseph is Associate Professor at the Institute for Studies in Industrial Development (ISID), New Delhi, India.
Date de parution : 08-2015
13.8x21.6 cm
Date de parution : 11-2017
13.8x21.6 cm
Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).
Prix indicatif 58,78 €
Ajouter au panierThèmes de Pharmaceutical Industry and Public Policy in Post-reform... :
Mots-clés :
bulk; drugs; indian; drug; price; firms; pharmaceuticals; sector; dosage; Bulk Drugs; product; Indian Pharmaceutical Industry; Ipr Regime; Tamil Nadu; Trip Agreement; IMS Health Data; MNC Subsidiary; Indian Pharmaceutical; IMS Health; Neglected Diseases; Drug Price Control; Trip Flexibility; Indian Pharmaceutical Sector; Indian Pharma Industry; DPCO; Data Exclusivity; RCA Index; Suven Life Sciences; Imatinib Mesylate; Beta Crystalline Form; Bulk Drug Manufacturing; Indian Pharmaceutical Firms; Essential Commodities Act; Dosage Forms; Ceiling Prices